Generate Biomedicines Logo

Generate Biomedicines

🇺🇸
GENB
US3709201004

Generate Biomedicines is revolutionizing drug discovery through the use of generative AI. The US-based company utilizes machine learning to program novel proteins and therapeutic agents, thereby accelerating biopharmaceutical research and the development of breakthrough therapies.

Next Quarterly Earnings

Thursday, May 6, 2027
Expected

Stock Price

Frequently asked questions

When did Generate Biomedicines last report quarterly earnings?

Generate Biomedicines last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.52 USD.

How do I add the Generate Biomedicines earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.55
Actual:
Q2 2026
Missed
Estimate:-$0.51
Actual:-$0.52
Difference:-$0.01
Price reaction (1 day):-4.1 %
Price reaction (7 days):+3.7 %
Q1 2026
Missed
Estimate:-$0.51
Actual:-$1.07
Difference:-$0.56
Price reaction (1 day):-11.2 %
Price reaction (7 days):+1.1 %

Company Information

Name
Generate Biomedicines
Ticker Symbol
GENB
ISIN
US3709201004
Country
🇺🇸
USA
Sector